Collectively, these findings suggest that SLC5A3 plays multifaceted roles in PDAC progression by regulating the key processes essential for tumor growth and survival, underscoring the potential of targeting SLC5A3 as a novel therapeutic strategy. This evidence concerns the gene SLC5A3 and neoplasm.